Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC.
about
Correlation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein bindingClinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.Searching for the Optimal Predictor of Ciprofloxacin Resistance in Klebsiella pneumoniae by Using In Vitro Dynamic Models.Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model.Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratio.Relationships of the area under the curve/MIC ratio to different integral endpoints of the antimicrobial effect: gemifloxacin pharmacodynamics in an in vitro dynamic model.Activity of trovafloxacin (with or without ampicillin-sulbactam) against enterococci in an in vitro dynamic model of infection.A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilitiesNet effect of inoculum size on antimicrobial action of ampicillin-sulbactam: studies using an in vitro dynamic model.Relationships between antimicrobial effect and area under the concentration-time curve as a basis for comparison of modes of antibiotic administration: meropenem bolus injections versus continuous infusionsParameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model.Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin.
P2860
Q28353204-EC1C6E0E-37AD-40B1-B091-57C064F0A9C0Q34529235-86181BCD-36D2-454D-AFCE-611221BCC576Q38740720-32E6F83E-C1F6-4B14-85F3-30296154E369Q39470200-D9186747-DA55-4231-BFAD-5A5E947E4FE7Q39473395-AF09D4F5-F036-4A86-8560-A3F2FA256E24Q39476666-F0F0F8B1-7AC8-4DA9-ADD6-9420C45560A4Q39556938-1BC32408-D601-4A9B-91C0-CF7971ADD2A4Q39559370-B2E270D3-B1A3-4B5D-8F1C-DA9CB3BF8654Q39783395-CD7DC4AA-D616-4675-9F02-1625082AD795Q39783646-35CE6D50-BEA2-4E22-992C-E9D86C33B8EDQ39784317-9CDB314F-40F3-445D-9CEE-138EB9159640Q42861027-DFA7D696-0214-4B9E-AF10-07B3CE105F2F
P2860
Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Predictors of effect of ampici ...... l: enzyme activity versus MIC.
@en
Predictors of effect of ampici ...... l: enzyme activity versus MIC.
@nl
type
label
Predictors of effect of ampici ...... l: enzyme activity versus MIC.
@en
Predictors of effect of ampici ...... l: enzyme activity versus MIC.
@nl
prefLabel
Predictors of effect of ampici ...... l: enzyme activity versus MIC.
@en
Predictors of effect of ampici ...... l: enzyme activity versus MIC.
@nl
P2093
P2860
P356
P1476
Predictors of effect of ampici ...... el: enzyme activity versus MIC
@en
P2093
Medeiros AA
Saverino D
P2860
P304
P356
10.1128/AAC.40.3.734
P407
P577
1996-03-01T00:00:00Z